GM 1998
Alternative Names: CeladinLatest Information Update: 07 Feb 2001
At a glance
- Originator Alberta Research Council
- Developer Alberta Research Council; Glycomed
- Class Anti-inflammatories; Antineoplastics
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Adult respiratory distress syndrome; Cancer; Inflammation; Reperfusion injury
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Adult respiratory distress syndrome in Canada (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Adult respiratory distress syndrome in USA (Unknown route)
- 07 Feb 2001 Discontinued-Preclinical for Cancer in Canada (Unknown route)